Geidel, G.; Adam, L.; Bänsch, S.; Fekade, N.; Deitert, B.; Rünger, A.; Kött, J.; Zell, T.; Heidrich, I.; Smit, D.J.;
et al. Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell Carcinoma. Cancers 2025, 17, 2162.
https://doi.org/10.3390/cancers17132162
AMA Style
Geidel G, Adam L, Bänsch S, Fekade N, Deitert B, Rünger A, Kött J, Zell T, Heidrich I, Smit DJ,
et al. Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell Carcinoma. Cancers. 2025; 17(13):2162.
https://doi.org/10.3390/cancers17132162
Chicago/Turabian Style
Geidel, Glenn, Laura Adam, Sabrina Bänsch, Nathan Fekade, Benjamin Deitert, Alessandra Rünger, Julian Kött, Tim Zell, Isabel Heidrich, Daniel J. Smit,
and et al. 2025. "Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell Carcinoma" Cancers 17, no. 13: 2162.
https://doi.org/10.3390/cancers17132162
APA Style
Geidel, G., Adam, L., Bänsch, S., Fekade, N., Deitert, B., Rünger, A., Kött, J., Zell, T., Heidrich, I., Smit, D. J., Pantel, K., Schneider, S. W., & Gebhardt, C.
(2025). Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell Carcinoma. Cancers, 17(13), 2162.
https://doi.org/10.3390/cancers17132162
